海报:ABCL-515 3期LOTIS-5试验安全性试验的最新结果:Loncastuximab Tesirine与Rituximab (Lonca-R)的新型联合治疗与免疫化疗治疗R/R DLBCL患者

{"title":"海报:ABCL-515 3期LOTIS-5试验安全性试验的最新结果:Loncastuximab Tesirine与Rituximab (Lonca-R)的新型联合治疗与免疫化疗治疗R/R DLBCL患者","authors":"M. Kwiatek, S. Grosicki, Javier López Jiménez, Sergio Felipe Pinzón Mariño, S. Snauwaert, E. Kingsley, Giovanna Zacchetti, Ying Wang, Luqiang Wang, J. Depaus","doi":"10.1016/s2152-2650(23)00729-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"182 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"POSTER: ABCL-515 Updated Results of the Safety Run-In of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL\",\"authors\":\"M. Kwiatek, S. Grosicki, Javier López Jiménez, Sergio Felipe Pinzón Mariño, S. Snauwaert, E. Kingsley, Giovanna Zacchetti, Ying Wang, Luqiang Wang, J. Depaus\",\"doi\":\"10.1016/s2152-2650(23)00729-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10370,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"182 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2152-2650(23)00729-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)00729-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}